Journals / Retina-Vitreus / 2012 / Cilt: 20 - Sayı: 1

Plasma and vitreous homocysteine levels in type 2 diabetic patients with proliferative retinopathy

Proliferatif retinopatili diyabetik hastalarda plazma ve vitreus homosistein düzeyleri

Pages
41–44
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no difference of Hcy levels between diabetic and control groups probably due to no severe breakdown of the blood-retina barrier.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate comparatively plasma and vitreous homosistein (Hcy) levels between the patients with proliferative diabetic retinopathy and the patients with nonproliferative ocular disease.
📊
Key Findings & Data:Material and Methods: Plasma and vitreous samples were obtained simultaneously at the time of vitreoretinal surgery from 16 type 2 diabetic patients with proliferative retinopathy and 13 nondiabetic patients with nonproliferative ocular diseases.
💡
Conclusion & Impact:There was no difference of Hcy levels between diabetic and control groups probably due to no severe breakdown of the blood-retina barrier.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To investigate comparatively plasma and vitreous homosistein (Hcy) levels between the patients with proliferative diabetic retinopathy and the patients with nonproliferative ocular disease. Material and Methods: Plasma and vitreous samples were obtained simultaneously at the time of vitreoretinal surgery from 16 type 2 diabetic patients with proliferative retinopathy and 13 nondiabetic patients with nonproliferative ocular diseases. Hcy levels were determined by high-performance liquid chromatography. Results: The vitreous and plasma Hcy concentrations for the diabetic group were (median;range) 1.4 mol/L (0.25-4.3) and 19.55 mol/L (1.8-39.8), respectively. The vitreous and plasma Hcy concentrations for the control group were (median; range) 1.8 mol/L (0.1-3) and 4 mol/L (2-17.2), respectively. Plasma Hcy concentrations for the diabetic group were significantly higher than those for the control group (p=0.004). A remarkable positive correlation between vitreous and plasma Hcy concentrations was present only for the diabetic group (Spearman’s, rho=0.487; p=0.056). Conclusion: Plasma Hcy levels in the patients with PDR were higher than control group. There was no difference of Hcy levels between diabetic and control groups probably due to no severe breakdown of the blood-retina barrier.

Özet

Amaç: Proliferative diyabetik retinopatisi olan hastalarda plazma ve vitreus homosistein (Hcy) seviyelerinin diyabetik olmayan olgular ile karşılaştırılmalı incelemek. Gereç ve Yöntem: Plazma ve vitreus örnekleri vitreoretinal cerrahi esnasında Tip 2 diyabetli proliferatif retinopatisi olan 16 hastadan ve 13 diyabeti olmayan oküler hastalıklı olgulardan alındı. Hcy düzeyleri yüksek performanslı sıvı kromatografi ile belirlendi. Bulgular: Vitreus ve plazma Hcy düzeyleri diyabetik grupta (ortanca; minimum-maksimum), 1.4 (0.25-4.3), 19.55 (1.8- 39.8) mol/L kontrol grupta vitreus ve plazma Hcy seviyeleri 1.8 (0.1-3); 4 (2-17.2) mol/L idi. Plazma Hcy düzeyleri diyabetik grupta kontrol grubuna göre istatistikî olarak anlamlı derecede yüksekti (p=0.004). Diyabetik grupta vitreus ve plazma Hcy konsantrasyonlar arası pozitif belirgin bir korelasyon mevcuttu (Spearman’s, rho=0.487; p=0.056). Sonuç: Plazma Hcy seviyesi PDR’li hastalarda kontrol grubuna göre yüksekti. Diyabetik ve kontrol gruplarının vitreus Hcy seviyeleri arasında farklılık olmaması kan-retina bariyerinin ileri düzeyde bozulmamasına bağlı olabilir.

🔖

Cite This Article

AYDIN, E., ŞAHİN, Ş. (2012). Plasma and vitreous homocysteine levels in type 2 diabetic patients with proliferative retinopathy. Retina-Vitreus, Cilt: 20 - Sayı: 1, 41–44. https://ajindex.com/articles/307683

References (14)

  1. Roybal CN, Yang S, Sun CW, et al. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcriptionfactor ATF4. J Biol Chem 2004;279:14844-52
  2. Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998;18:133-8
  3. Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57
  4. Buysschaert M, Dramais AS, Wallemacq PE, et al. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care 2000;23:1816-22
  5. Looker HC, Fagot-Campagna A, Gunter EW, et al. Homocysteine as a risk factor for nephropathy and retinopathy in type 2 diabetes. Diabetologia 2003;46:766-72
  6. Vaccaro O, Perna AF, Mancini FP, et al. Plasma homocysteine and its determinants in diabetic retinopathy. DiabetesCare 2000;23:1026-1027
  7. Vaccaro O, Perna AF, Mancini FP, et al. Plasma homocysteine and microvascular complications in type 1 diabetes.Nutr Metab Cardiovasc Dis 2000;10:297-304
  8. Wang H, Yoshizumi M, Lai K, et al. Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteinebut not cysteine. J Biol Chem 1997;272:25380-5
  9. Lentz SR, Sobey CG, Piegors DJ, et al. Vascular dysfunctionin monkeys with diet-induced hyperhomocyst(e)inemia.J Clin Invest 1996;98:24-9
  10. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 1996;98:5-7
  11. Axer-Siegel R, Bourla D, Ehrlich R, et al. Association of neovascular age-related macular degeneration and hyperhomocysteinemia. Am J Ophthalmol 2004;137:84-9
  12. Kamburoglu G, Gumus K, Kadayifcilar S, et al. Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2006;244:565-9
  13. Lee I, Lee H, Kim JM, et al. Short-term hyperhomocysteinemia- induced oxidative stress activates retinal glial cells and increases vascular endothelial growth factor expression in rat retina. Biosci Biotechnol Biochem 2007;71:1203-10
  14. Ndrepepa G, Kastrati A, Braun, et al. Circulating homocysteine levels in patients with type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2008;18:66-73.